FDA Inspection
Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited – FDA Inspection, Nov 26, 2025
Record Details
This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on November 26, 2025, issued by the Chicago District Office, covering biologics.
View Company Profile
ID · 1a77ba55-396a-4912-81d2-ff91a8e53f0c
Inspection Facts
- Inspection number
- 1293098
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
5- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Takeda Pharmaceutical Company Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 25, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Takeda Pharmaceutical Company Limited
- FDA Inspection 1179911 - 2022-09-15
- FDA Inspection 1103189 - 2019-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.